Harlequin ichthyosis (HI) is one of the most devastating genodermatoses.
Harlequin ichthyosis (HI) (MIM #242500) is a severe and often fatal congenital ichthyosis with an autosomal recessive inheritance pattern (Williams and Elias, 1987; Akiyama, 1999; Judge et al, 2004) .
In 2005, ABCA12 mutations were identified in HI families (Akiyama et al, 2005; Kelsell et al, 2005) . The pathomechanisms of HI became known when functional defects in the lipid transporter ABCA12 were shown to cause abnormal lipid transport via lamellar granules (LGs) in the keratinocytes, resulting in malformation of the patient's intercellular lipid layers of the stratum corneum (Akiyama et al, 2005) . However, genotype/phenotype correlations in HI cases with ABCA12 mutations have yet to be fully elucidated (Akiyama, in press a).
In the study of this case, we have found a compound heterozygous ABCA12 combination of mutations, a novel de novo missense mutation, S387N, in exon 10 and a maternal deletion mutation T1387del in exon 28 in a newborn HI baby.
In the majority of HI patients, deletion or truncation mutations seriously affecting ABCA12 function were found. However, in the present case, one mutation was a missense mutation located in the cytoplasmic region of ABCA12 polypeptide, not in the transmembrane domain or the ATP binding cassettes. The nature and site of mutations might be the key to the relatively moderate phenotype of this HI patient.
In addition, the novel mutation S387N was the first reported de novo mutation in ABCA12. Our case suggested the possibility that de novo mutations can cause the occurrence of HI in non-consanguineous families. 3 The patient was a newborn Japanese male. He was born at 33 weeks and 3 days pregnancy by premature, vaginal delivery (body weight 1876g). He was the first child of non-consanguineous healthy parents. There was no family history of congenital ichthyosis. At birth, the patient had presented with severe hyperkeratosis over his entire body, severe ectropion, eclabium and malformed pinnae (Fig 1) . The patient's clinical features at birth were characteristic of typical HI. He was admitted into a neonatal intensive care unit and had oral etretinate treatment (1 mg/kg/day). At this time, light microscopy of the lesional skin sample from the patient's trunk showed marked hyperkeratosis with only a small number of parakeratotic cells. At the age of one year, the patient showed dark brownish, thick scales over the entire body surface including the face, palms and the soles.
RESULTS

Clinico-pathological features of the patient
ABCA12 mutation analysis
Mutation analysis of the 53 exons including the intron-exon boundaries of the entire ABCA12 gene revealed a 1160G>A transition in exon 10 and one previously reported deletion mutation 4158_4160delTAC in exon 28 in each allele in a compound heterozygous fashion in the patient [sequence according to Lefèvre et al. (2003) ] (GenBank accession NM 173076) (Fig 2) . The mutation 1160G>A transition was a novel missense mutation that changed a serine residue of codon 387 to an asparagine residue (S387N). This missense mutation S387N was not found in either in the parent's (father or mother), although the patient's mother was heterozygous for the deletion mutation 4158_4160delTAC (Fig 2) . Thus, the missense mutation S387N was thought to be a de novo mutation and the deletion mutation was a maternal mutation. Paternity testing by microsatellite marker analysis proved the father was the patient's true genetic father (data not shown). These mutations were not found in 200 normal, unrelated Japanese alleles (100 normal unrelated Japanese individuals) by sequence analysis, and were unlikely to be a polymorphism (data not shown). 4 The deletion mutation 4158_4160delTAC led to an in-frame deletion of a highly conserved threonine residue at codon 1387 (T1387del) within the first ATP-binding domain of ABCA12. Thus, the deletion mutation is thought to seriously affect either the function or specific critical structures of the ABCA12 protein (Akiyama et al, 2005) .
Ultrastructure of the patient's skin
Electron microscopy revealed that, in the keratinocyte cytoplasm of the granular layer, no normal LGs were apparent. Lipid droplets, vacuoles and multivesiculated bodies were seen in keratinocytes in the keratinized and granular cell layers (Figs 3a,b) . The number of abnormal lipid droplets in the keratinized stratum corneum cells was smaller than that in skin samples from HI patients harboring the homozygous splice acceptor site mutation IVS23-2A>G of ABCA12 (Akiyama et al, 2005) (Fig 3c) , although the number of lipid vacuoles was larger than those in lamellar ichthyosis patients with ABCA12 mutations (data not shown). Cornified cell envelope formation was normal in the granular and cornified layer cells (Fig 3e) .
Distribution of ABCA12 and glucosylceramide in patient's skin
Immunofluorescence studies revealed that ABCA12 was positive in the upper epidermal layers, mainly in the granular layers, of normal human skin (Fig 4c) .
In the epidermis of the present patient, reduced ABCA12 immunostaining was seen in the upper epidermis (Fig 4a) , compared with seriously reduced immunolabeling in epidermal keratinocytes from the HI patient harboring a homozygous splice acceptor site mutation IVS23-2A>G (Fig 4b) (Akiyama et al, 2005) . These findings confirmed that the present patient expresses a significant amount of mutated ABCA12 protein in his epidermis.
Immunofluorescent staining showed that glucosylceramide, a major lipid component of LGs (Vielhaber et al, 2001; Ishida-Yamamoto et al, 2004) and an 5 essential component of the epidermal permeability barrier (Holleran et al, 1993) , was sparsely distributed in the patient's upper epidermis (Fig 4a) , compared with a restricted, intense distribution in the granular layers of normal skin ( Fig   4c) . The condensed glucosylceramide staining was not seen in the patient's granular layers (Fig 4a) .
Abnormal glucosylceramide transport in patient's cultured keratinocytes
Culture of the patient's keratinocytes under high-Ca 2+ conditions (2.0 mM) induced a large number of cells to express condensed glucosylceramide staining around the nuclei, and this glucosylceramide failed to become localized to the periphery of the keratinocyte cytoplasm (Fig 5a) . Culture of normal human keratinocytes in high-Ca 2+ conditions exhibited a more diffuse glucosylceramide staining throughout the cytoplasm (Fig 5b) .
DISCUSSION
The ATP-binding cassette (ABC) transporter superfamily is one of the largest gene families, encoding a highly conserved group of proteins involved in energy-dependent active transport (Higgins, 1992; Allikmets et al, 1996; Dean et al, 2001; Borst and Elferink, 2002) and, recently, this superfamily has been highlighted in the dermatology fields (Uitto, 2005) . The ABCA subfamily is suggested to work in lipid transport (Hayden et al, 2000; Orso et al, 2000; Schmitz and Langmann, 2001; Weng et al, 1999; Peelman et al, 2003) and has received considerable attention (Klein et al, 1999) because mutations in these genes have been implicated in several human genetic diseases (Allikmets et al, 1997a; Allikmets et al, 1997b; Brooks-Wilson et al, 1999; Rust et al, 1999; Oram, 2002) . Keratinocyte LGs are known lipid transporting organelles and LG contents are secreted into the intercellular space, forming an intercellular lipid layer between the granular layer cells and keratinized cells in the stratum corneum. Our previous study (Akiyama et al, 2005) has clearly demonstrated 6 that ABCA12 functions in the transport of endogenous lipid to the keratinocyte cell periphery via LGs.
The abnormal
LGs in the granular layer keratinocytes and a lack of extracellular lipid lamellae reflect the defective lipid transport via LGs and the malformation of intercellular stratum corneum lipid layer in HI (Akiyama, in press a). In 2005, ABCA12 mutations that seriously affect its function were shown to cause a loss of the skin lipid barrier, leading to HI (Akiyama et al, 2005) . In addition to HI with defective lipid layers in the stratum corneum, ichthyosis syndromes are also thought to share similar pathomechanisms (Akiyama, in press b) . For example, Dorfman-Chanarin syndrome (neutral lipid storage disease) showed malformation of LGs and defective lipid production in LGs caused by a deficiency in the CGI-58 protein that is thought to be involved in the pathogenesis of this form of ichthyosis (Akiyama et al, 2003) . In Sjögren-Larsson syndrome harboring fatty aldehyde dehydrogenase (FALDH) gene (ALDH3A2) mutations, defective LG formation was reported as one sign of a putative pathogenetic mechanism (Shibaki et al, 2004) . Recently, mutations in a new gene, FLJ39501, encoding a cytochrome P450, family 4, subfamily F, polypeptide 2 homolog of the leukotriene B4-ω-hydroxylase (CYP4F2) were reported to underlie lamellar ichthyosis cases linked to chromosome 19p12-q12 (Lefèvre et al, 2006) . These facts further support the idea that abnormal LG lipid contents and defective intercellular lipid are prevailing concepts of pathogenetic mechanisms in the ichthyoses.
In the present case based on the reported amino acids sequence (Annilo et al, 2002) , the deletion mutation 4158_4160delTAC led to an in-frame deletion of a threonine residue at codon 1387 (T1387del) within the first ATP-binding domain of ABCA12 protein (Fig 6) . This threonine residue is a highly conserved residue between diverse species and is thought to be important in the 7 function of ABCA12 (Akiyama et al, 2005) . Indeed, a compound heterozygous patient with this deletion mutation and a separate ABCA12 truncation mutation was previously reported as a typical HI newborn who died 15 days after birth (Akiyama et al, 2005) .
The novel de novo mutation S387N in the present patient is located outside all of the known ABCA12 active transporter sites, within the cytoplasmic domain between the transmembrane domains and the first ATP binding cassette (Fig 6) .
Both serine and asparagine are neutral amino acids with small side chains and this missense mutation would be expected to not significantly affect the conformation of ABCA12 molecule. Thus, one would predict the de novo missense mutation S387N not to lead to a serious ABCA12 functional loss.
Considering the nature and site of the ABCA12 mutations in this case, we suggest that a combination of the deletion mutation and the missense mutation leads to the current patient's HI phenotype with a moderate clinical severity.
In type 2 lamellar ichthyosis, a relatively mild form of congenital ichthyosis, all five reported ABCA12 mutations were missense mutations that resulted in only one amino acid alteration (Lefèvre et al, 2003) . Conversely, in our previous study on HI families, no ABCA12 missense mutations were identified and most of the defects led to severe truncation of ABCA12 peptide, affecting important nucleotide binding fold domains and/or transmembrane domains (Akiyama et al, 2005) . The other, non-truncation mutations in HI were deletion mutations affecting highly conserved ABCA12 sequences (Akiyama et al, 2005) . Thus, it was thought that only truncation or deletion mutations in conserved regions, which seriously affect the function of the ABCA12 transporter protein, can lead to the HI phenotype. 8 In an additional series of HI patients, most ABCA12 mutations were homozygous truncation mutations (Kelsell et al, 2005) . Only one mutation in one HI patient was a missense mutation and the patient was heterozygous for a truncation mutation and the missense mutation.
Recently, the prognosis of newborns affected with HI has improved, owing to better targeted oral retinoid treatment. More than half of HI newborns including cases with a serious functional loss of ABCA12 survive beyond the perinatal period (Akiyama et al, 2005; in press a). Thus, it is difficult to discuss genotype/phenotype correlations and quality of life prognosis for ABCA12 mutations in HI.
Most families with HI or lamellar ichthyosis caused by ABCA12 mutations were consanguineous and, in those families, causative ABCA12 mutations were homozygous mutations inherited with an autosomal recessive trait. No de novo mutation has yet been reported in ABCA12, as far as we know (Lefèvre et al, 2003; Akiyama et al, 2005; Kelsell et al, 2005) . The present novel missense mutation S387N in our case was the first de novo mutation reported in ABCA12.
The genetic information of whether the causative mutations are inherited or de novo is very important for genetic counseling in severe genetic disorders such as HI. Indeed, in the present family, the parents had requested a prenatal diagnosis of HI for their subsequent pregnancy. However, we have demonstrated that the missense mutation was a de novo mutation and that the patient's father was not a carrier of any ABCA12 mutation. Thus, the family could be spared of the worry of an unnecessary HI prenatal diagnosis for the subsequent pregnancy almost, although we cannot completely exclude the possibility that the father has a mosaic mutation affecting his germ line. The present case suggested that, in non-consanguineous HI families, a de novo ABCA12 mutation might be one 9 source of mutations and underlines that the detection of causative ABCA12 mutations is essential for the genetic counseling for HI.
MATERIALS AND METHODS
Mutation detection
Mutational analysis was performed in the affected baby and the parents. Briefly, genomic DNA isolated from peripheral blood was subjected to PCR amplification, followed by direct automated sequencing using an ABI PRISM 3100 genetic analyzer (ABI Advanced Biotechnologies, Columbia, MD). Oligonucleotide primers and PCR conditions used for amplification of all exons 1-53 of ABCA12 were originally derived from the report by Lefèvre et al. (2003) and were partially modified for the present study.
The entire coding region including the exon/intron boundaries for both forward and reverse strands from the patient, family members and 100 healthy Japanese controls were sequenced. No mutations were found in 200 normal alleles from the healthy Japanese population. Paternity testing was carried out using 16 microsatellite markers.
Ultrastructural observations Skin biopsy samples were fixed in 5 % glutaraldehyde solution, post-fixed in 1% OsO4, dehydrated, and embedded in Epon 812. The samples were sectioned at 1 µm thickness for light microscopy and thin sectioned for electron microscopy (70 nm thick). The thin sections were stained with uranyl acetate and lead citrate and examined in a transmission electron microscope. As controls, lesional skin samles from lamellar ichthyosis patients with transglutaminase 1 gene mutations (Akiyama et al, 2001) or ABCA12 mutations were also studied.
Cell culture
A skin sample from the patient was processed for primary keratinocyte culture, and cells were grown according to standard procedures in defined 10 keratinocyte serum-free medium (Invitrogen Corp, Carlsbad, CA). After several passages in low-Ca 2+ (0.09 mM) conditions, cultures were grown in high-Ca 2+ (2.0 mM) conditions. Antibodies Polyclonal anti-ABCA12 antiserum was raised in rabbits using a 14 amino acids sequence synthetic peptide (residues 2567-2580) derived from the ABCA12 sequence (NM 173076) as the immunogen (Akiyama et al, 2005) . The other primary antibody was mouse monoclonal anti-glucosylceramide antibody (Alexis Biochemicals, Lausanne, Switzerland).
Immunofluorescent labeling
Immunofluorescent labeling was performed as previously described (Akiyama et al, 2000) . Briefly, 6-µm-thick sections of fresh patient's skin was cut using a cryostat. The sections were incubated in primary antibody solution for 1 h at 37˚C. Antibody dilutions were as follows; 1/10 for anti-ABCA12 antiserum and 1/10 for anti-glucosylceramide antibody. The sections were then incubated in fluorescein isothiocyanate-conjugated to rabbit anti-mouse immunoglobulins and TRITC-conjugated goat anti-rabbit immunoglobulins diluted 1:100 (DAKO, Glostrup, Denmark) for 30 min at room temperature, followed by nuclear counterstain by TO-PRO-3 (Invitrogen, Carlsbad, CA, USA). The sections were extensively washed with phosphate-buffered saline between incubations. The stained sections were then mounted with a cover slip and observed using a confocal laser scanning microscope. Mutations in the present HI patient are marked by red arrows. Note that the de novo missense mutation S387N is located in the intracytoplasmic region between the N-terminus and the first transmembrane domain, not in any active sites, and the other, deletion mutation T1387del is within the first ATP-binding cassette, which is thought to be important for ABCA12 lipid transporter activity.
